Haplotype architecture of the norepinephrine transporter gene SLC6A2 in four populations

Journal of Human Genetics

Volumn 49, Issue 5, 2004, Pages 232-245

  Belfer, Inna ^a,b   Phillips, Gabriel ^a,b   Taubman, Julie ^b   Hipp, Heather ^a,b   Lipsky, Robert H ^b   Enoch, Mary Anne ^b   Max, Mitchell B ^a   Goldman, David ^b  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Haplotype; Linkage disequilibrium; Norepinephrine transporter; Single nucleotide polymorphism; SLC6A2

Indexed keywords

MONOAMINE; NORADRENALIN TRANSPORTER;

AMERICAN INDIAN; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR; CANADA; CAUCASIAN; EVIDENCE BASED MEDICINE; FINLAND; GENE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; NORMAL HUMAN; PHENOTYPE; POPULATION GENETICS; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SLC6A2 GENE; UNITED STATES;

AFRICAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FINLAND; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HAPLOTYPES; HUMANS; INDIANS, NORTH AMERICAN; LINKAGE DISEQUILIBRIUM; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SYMPORTERS; UNITED STATES;

EID: 3042754669     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-004-0140-9     Document Type: Article

References (33)

1. Backs J, Haunstetter A, Gerber SH, Metz J, Borst MM, Strasser RH, Kubler W, Haass M (2001) The neuronal norepinephrine transporter in experimental heart failure: evidence for a post-transcriptional downregulation. J Mol Cell Cardiol 33:461-472
2. Bohm M, La Rosee K, Schwinger RH, Erdmann E (1995) Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol 25:146-153
3. Bohm M, Castellano M, Flesch M, Maack C, Moll M, Paul M, Schiffer F, Zolk O (1998) Chamber-specific alterations of norepinephrine uptake sites in cardiac hypertrophy. Hypertension 32:831-837
4. Brüss M, Kunz J, Lingen B, Bönisch H (1993) Chromosomal mapping of the human gene for the tricyclic antidepressant-sensitive noradrenaline transporter. Hum Genet 91:278-280
5. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27:699-711
6. Esler M, Jackman G, Bobik A, Leonard P, Kelleher D, Skews H, Jennings G, Korner P (1981) Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients. Hypertension 3:149-156
7. Foote SL, Bloom FE, Aston-Jones G (1983) Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol Rev 63:844-914
8. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225-2229
9. Gu HH, Wall S, Rudnick G (1996) Ion coupling stoichiometry for the norepinephrine transporter in membrane vesicles from stably transfected cells. J Biol Chem 271:6911-6919
10. Hahn MK, Blakely RD (2002) Gene organization and polymorphisms of monoamine transporters. Relationship to psychiatric and other complex diseases. In: Reith MEA (ed) Neurotransmitter transporters. Structure, function, and regulation, Humana, Totowa, NJ, pp 111-169
11. Hahn MK, Robertson D, Blakely RD (2003) A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters. J Neurosci 23:4470-4478
12. Ivancsits S, Heider A, Rudiger HW, Winker R (2003) Orthostatic intolerance is not necessarily related to a specific mutation (Ala457Pro) in the human norepinephrine transporter gene. Am J Med Sci 325:63-65
13. Iversen LL (1974) Uptake mechanisms for neurotransmitter amines. Biochem Pharmacol 23:1927-1935
14. Jasmin L, Tien D, Weinshenker D, Palmiter RD, Green PG, Janni G, Ohara PT (2002) The NKI receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline. Proc Natl Acad Sci 99:1029-1034
15. Jordan S, Kramer GL, Zukar PK, Moeller M, Petty F (1994) In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine. Synapse 18:294-297
16. Leszczynska-Rodziewicz A, Czerski PM, Kapelski P, Godlewski S, Dmitrzak-Weglarz M, Rybakowski J, Hauser J (2002) A polymorphism of the norepinephrine transporter gene in bipolar disorder and schizophrenia: lack of association. Neuropsychobiology 45:182-185
17. Long JC, Williams RC, Urbanek M (1995) An E-M algorithm and testing strategy for multiple locus haplotypes. Am J Hum Genet 56:799-810
18. Merlet P, Dubois-Rande JL, Adnot S, Bourguignon MH, Benvenuti C, Loisance D, Valette H, Castaigne A, Syrota A (1992) Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 19:10-16
19. - neurotransmitter transporters. J Neurochem 71:1785-1803
20. Pacholczyk T, Blakely RD, Amara SG (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350:350-354
21. Pörzgen P, Bönisch H, Brüss M (1995) Molecular cloning and organization of the coding region of the human norepinephrine transporter gene. Biochem Biophys Res Commun 215:1145-1150
22. Pörzgen P, Bönisch H, Hammermann R, Brüss M (1998) The human noradrenaline transporter gene contains multiple polyadenylation sites and two alternatively spliced C-terminal exons. Biochim Biophys Acta 1398:365-370
23. Ritz MC, Cone EJ, Kuhar MJ (1990) Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci 46:635-645
24. Sacchetti G, Bernini M, Bianchetti A, Parini S, Invernizzi RW, Samanin R (1999) Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain. Br J Pharmacol 128:1332-1338
25. Samochowiec J, Kucharska-Mazur J, Kaminski R, Smolka M, Rommelschpacher H, Wernicke C, Tymicz A, Schmidt LG (2002) Norepinephrine transporter gene polymorphism is not associated with susceptibility to alcohol dependence. Psychiatry Res 111:229-233
26. Schnell O, Muhr D, Weiss M, Dresel S, Haslbeck M, Standl E (1996) Reduced myocardial 1231-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Diabetes 45:801-805
27. Schomig E, Fischer P, Schonfeld CL, Trendelenburg U (1989). The extent of neuronal re-uptake of 3H-noradrenaline in isolated vasa deferentia and atria of the rat. Arch Pharmacol 340:502-508
28. Shi MM, Myrand SP, Bleavins MR, de la Iglesia FA (1999) High throughput genotyping for the detection of a single nucleotide polymorphism in NAD(P)H quinone oxidoreductase (DT diaphorase) using TaqMan probes. Mol Pathol 52:295-299
29. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989
30. Stober G, Nothen MM, Porzgen P, Bruss M, Bonisch H, Knapp M, Beckmann H, Propping P (1996) Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Genet 67:523-532
31. Tanda G, Pontier FE, Frau R. DiChiara G (1997) Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 9:2077-2085
32. Tatsumi M, Groshan K, Blakely RD, Richelson E (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249-258
33. Zahniser NR, Doolen S (2001) Chronic and acute regulation of Na+/Cldependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol Ther 92:21-55